Navigation Links
HeartWare and Dualis MedTech Announce Agreement to Develop Fully Implantable Ventricular Assist System
Date:1/9/2012

expansion of our pipeline utilizing new technologies generated by our new European partners."

"At Dualis, our primary focus with this first initiative with HeartWare is to harness our proprietary and established energy transfer system to work with its HVAD and MVAD pumps," explained Dr. Thomas Schmid, CEO and Managing Director for Dualis MedTech.  "We have already conducted over a dozen animal studies of our TETS technology, which gives us great confidence in the integrity of our system.  We are delighted to now have an opportunity to marry our advanced system with the leading LVAD technology and look forward to a long and productive partnership with HeartWare as we pursue our mission of creating intelligent implants to treat poorly managed medical conditions."

The Dualis wireless energy transfer system for implantable devices is designed to allow patients to safely and efficiently provide power during normal daily activities.  By coupling an external "sender" coil with an implanted "receiver" coil, the TETS system is able to transfer electricity through the patient's skin, thereby eliminating the traditional power and transmitter cable utilized in ventricular assist devices today.

Additional terms of the agreement were not disclosed.

About Dualis

DUALIS is a young and highly innovative medical technology company that specializes in the area of active implants.  The company offers research and development services, as well as its own technologies developed in close collaboration with the German Aerospace Center.  For more information, please visit http://www.dualis-medtech.de/.  Dualis, a subsidiary of AVRA Surgical, is a spin-off from the German Aerospace Centre (DLR). 

DLR is Germany's national research center for aeronautics and space.  Its extensive research and development work in aeronautics, space, transportation and energy is
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Presentation of HeartWare Clinical Results
2. HeartWare International Clinical Trial Shows 90% Survival at 180 Days
3. U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial
4. HeartWare International Reports Third Quarter Revenues of $7.5 Million
5. HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City
6. HeartWare to Present at the UBS 2010 Global Life Sciences Conference
7. HeartWare to Present at Lazard Capital Markets Circulatory Assist Device Day
8. HeartWare to Report Financial Results for Third Quarter of 2010
9. HeartWare International Reports Third Quarter 2010 Revenues of $13.8 Million; Compared to $7.5 Million in Third Quarter of 2009
10. HeartWare Bridge-to-Transplant Data Featured as Late Breaking Clinical Trial at American Heart Association Scientific Sessions 2010
11. HeartWare to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a ... the pharmaceutical, biotechnology and medical device industries, with operations ... the United States , today announced that it ... after the New York Stock Exchange closes on Thursday, ... 14, 2015 Shanghai time). The earnings release will be ...
(Date:7/29/2015)... (NASDAQ: NBIX ) today announced its financial results for the ... the Company reported a net loss of $24.0 million, or $0.28 ... or $0.18 loss per share, for the same period in 2014. ... a net loss of $25.2 million, or $0.30 loss per share, ... per share, for the first half of last year. ...
(Date:7/29/2015)... 29, 2015 Sangamo BioSciences, Inc. (NASDAQ: ... its second quarter 2015 financial results after the market ... will be followed by a conference call at 5:00 ... via telephone and webcast. During the conference call, the ... other business matters. The conference call dial-in ...
Breaking Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2015 Earnings Release 2Neurocrine Biosciences Reports Second Quarter 2015 Results 2Neurocrine Biosciences Reports Second Quarter 2015 Results 3Neurocrine Biosciences Reports Second Quarter 2015 Results 4Neurocrine Biosciences Reports Second Quarter 2015 Results 5Neurocrine Biosciences Reports Second Quarter 2015 Results 6Neurocrine Biosciences Reports Second Quarter 2015 Results 7Neurocrine Biosciences Reports Second Quarter 2015 Results 8Neurocrine Biosciences Reports Second Quarter 2015 Results 9Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast 2
... shows that,polyunsaturated fatty acids (PUFAs), mainly the omega-3s ... function and total parenteral,nutrition (TPN). The June 2008 ... new findings in these areas., One study ... an omega-3 PUFA, and arachidonic acid, an omega-6 ...
... a,division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced today,that the ... pediatric,exclusivity for TOPAMAX(R) (topiramate), based on studies submitted ... to investigate the use of TOPAMAX,in pediatric patients ... seizures., In addition to granting pediatric exclusivity, ...
Cached Medicine Technology:Omega-3 Fatty Acids Critical to Infants, Mothers and the Seriously Ill 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3
(Date:7/29/2015)... ... July 29, 2015 , ... ... for a five-year period, expiring November 30, 2019, during its recent meeting. , ... an application demonstrating the program’s compliance with the NCCA’s Standards for the Accreditation ...
(Date:7/29/2015)... ... ... This year, the threat of flooding is higher in many areas of North ... is not far behind. Paul Davis, a leading provider of property restoration services for ... Davis is regularly called on to handle these types of emergencies, although much of ...
(Date:7/29/2015)... ... ... According to the Miami Herald on July 18th acupuncture helps ... Acu-detox may begin taking off in the South Florida community as more detox centers ... is not a new practice, it is not widely used, but has yielded positive ...
(Date:7/29/2015)... Waukesha, WI (PRWEB) , ... July 29, 2015 ... ... area, Scott Campbell Agency has once again teamed up with Stillwaters Cancer Support ... patients and their families. Stillwaters provides individual and family counseling, support groups, workshops ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Orthopedic surgeons ... now offer the Rotation Medical Rotator Cuff System, a new implant to treat a ... is designed to foster natural regeneration of additional tendon tissue, which could allow for ...
Breaking Medicine News(10 mins):Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 2Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 3Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 2Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 3Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3
... development of a digital screening device it says ... the third most common cancer in Australia. Victor ... terms of its ability to diagnose melanomas, it ... diagnostic software for SolarScan, which has been under ...
... France observed in a study that red wine drinkers ... "good" cholesterol. This helps show some light on why ... disease. // ,Researchers compared HDL cholesterol levels between ... who are regular drinkers and those who are heavy ...
... Researchers at the University of Michigan, made a new ... help patients after head and neck surgery. Ann Arbor say ... transfers.Patients who have surgery// to remove cancer in and around ... performed. ,Doctors say about 15 percent of patients develop ...
... able to differentiate those who will get Alzheimer's disease from ... older people - so we can expect an increase in ... now available and they seem to work best if they ... ,Researchers at the University of Toronto have been analysing ...
... University of Illinois, confirmed that a compound modelled on ... breast cancer. Previous research has suggested that sulforaphane,// which ... cancer. It does so by increasing the level of ... sulforaphane are toxic to cells so it may not ...
... to a new study, it is found that antioxidant treatment ... disease. Peripheral artery disease is a narrowing of the arteries ... 5 million to 10 million people in the United States ... the major signs of the condition is leg pain as ...
Cached Medicine News:Health News:Latest device for identifying Melanomas 2
Mcintyre straight lachrymal cannula, closed end, two side ports at 0.3 mm, straight shaft....
McIntyre lacrimal cannula, dual 0.3 mm side ports, straight....
Lacrimal cannula, malleable tip, straight....
Button Tip Manipulator, 0.50 mm diameter button tip, angled 45 degrees, 15 mm from tip to bend....
Medicine Products: